ResMed Inc. (RMD) Next Earnings Date & Options-Implied ±6.7% Move
ResMed Inc. (RMD) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (59% profit margin, 23% return on capital) with steady institutional support. Even if the broader market gets choppy, the company’s underlying cash engine and big-money support put the odds in buyers’ favor.
Options-Implied Post-Earnings ±6.7% Bell Curve
Will RMD Beat & Rip or Miss Next Quarter?
Trailing EPS: $9.96 • YoY Revenue Growth: 9.8%
Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence
| Period | Filed | Revenue | Net Profit | Free Cash Flow | Gross Margin |
|---|---|---|---|---|---|
| FY 2025 | 2025-06-30 | $5.15B | $1.40B | $1.66B | 59.4% |
| FY 2024 | 2024-06-30 | $4.69B | $1.02B | $1.30B | 56.7% |
| FY 2023 | 2023-06-30 | $4.22B | $898.0M | $503.3M | 44% |
Whale Flow & Momentum Playbook: Trading RMD & AI Leaders Without Chasing Tops
- ✓Exact institutional whale strikes & implied earnings range on RMD this week
- ✓How active traders scale setups using funded prop-firm accounts instead of risking savings
- ✓Free bonus: instant RQD Rating Flip alerts on all tracked momentum leaders
RMD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +9.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on RMD today. View full Setup Ledger →
RMD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhen is RMD's next earnings date?
Based on SEC filing cadence, ResMed Inc. (RMD)'s next quarterly earnings window is estimated around Dec 28, 2026.
How much is RMD stock expected to move on earnings?
Options markets currently imply a ±6.7% post-earnings move for RMD, projecting a trading range between $235.89 and $269.77.